product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Smurf2 (D8B8) Rabbit mAb
catalog :
12024
clonality :
monoclonal
host :
domestic rabbit
conjugate :
nonconjugated
clone name :
D8B8
reactivity :
human, mouse, rat
application :
western blot, immunoprecipitation, immunohistochemistry - paraffin section, western blot knockout validation
citations: 3
Published Application/Species/Sample/DilutionReference
  • western blot knockout validation; mouse; 1:1000; loading ...; fig 6c
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig s7a
Kushioka J, Kaito T, Okada R, Ishiguro H, Bal Z, Kodama J, et al. A novel negative regulatory mechanism of Smurf2 in BMP/Smad signaling in bone. Bone Res. 2020;8:41 pubmed publisher
  • western blot; human; loading ...; fig 5a
Nam B, Park H, Lee Y, Oh Y, Park J, Kim S, et al. TGFβ1 Suppressed Matrix Mineralization of Osteoblasts Differentiation by Regulating SMURF1-C/EBPβ-DKK1 Axis. Int J Mol Sci. 2020;21: pubmed publisher
  • western blot; human; 1:1000; loading ...; fig 4d
Li J, Wang P, Xie Z, Wang S, Cen S, Li M, et al. TRAF4 positively regulates the osteogenic differentiation of mesenchymal stem cells by acting as an E3 ubiquitin ligase to degrade Smurf2. Cell Death Differ. 2019;: pubmed publisher
product information
SKU :
12024S
Product-Name :
Smurf2 (D8B8) Rabbit mAb
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, M, R, Mk
Applications :
Immunoprecipitation
Product-Category :
Developmental Biology
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
80
Host :
Rabbit
Target :
SMURF2
Primary-Protein :
SMURF2
Alt-Names :
DKFZp686F0270,E3 ubiquitin ligase SMURF2,E3 ubiquitin-protein ligase SMURF2,MGC138150,SMAD specific E3 ubiquitin protein ligase 2,SMAD ubiquitination regulatory factor 2,SMAD-specific E3 ubiquitin-protein ligase 2,SMUF2,SMURF2,hSMURF2
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
https://www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.